Dendritic cells in multiple myeloma: from immune evasion to therapeutic potential
Multiple myeloma (MM) is a type of hematologic cancer characterized by the uncontrolled clonal expansion of plasma cells in the bone marrow (BM). This leads to significant dysfunction and suppression of the immune system in affected patients. Myeloma cells employ sophisticated strategies to manipula...
Saved in:
| Main Authors: | Melanie Andrea Jordan, Johannes Morschl, Stella E. Autenrieth |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1575509/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chemotherapy‐Mediated Induction of PD‐L1 via SEI1 Facilitates Myeloma Immune Evasion
by: Rui Chen, et al.
Published: (2025-05-01) -
Comprehensive analysis of exosome-related gene signature in multiple myeloma prognosis and immune microenvironment evaluation
by: Dong Zheng, et al.
Published: (2025-07-01) -
Research progress of the immunosuppressive tumor microenvironment in multiple myeloma
by: Yue WANG, et al.
Published: (2025-08-01) -
Dendritic Cell-Based Cancer Vaccines: The Impact of Modulating Innate Lymphoid Cells on Anti-Tumor Efficacy
by: Yeganeh Mehrani, et al.
Published: (2025-05-01) -
Molecular insights unlocking therapeutic potential for multiple myeloma and bone disease management
by: Tiziana Bruno, et al.
Published: (2024-12-01)